Structural and functional studies of ALIX interactions with YPX nL late domains of HIV-1 and EIAV

Nature Structural and Molecular Biology

Volumn 15, Issue 1, 2008, Pages 43-49

  Zhai, Qianting ^a   Fisher, Robert D ^a   Chung, Hyo Young ^a   Myszka, David G ^a   Sundquist, Wesley I ^a   Hill, Christopher P ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PROTEIN ALIX; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CRYSTAL STRUCTURE; EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL MEMBRANE; CONSERVED SEQUENCE; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; INFECTIOUS ANEMIA VIRUS, EQUINE; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; VIRAL PROTEINS;

EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 37849024338     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb1319     Document Type: Article

References (52)

1. Demirov, D.G. & Freed, E.O. Retrovirus budding. Virus Res. 106, 87-102 (2004).
2. Bieniasz, P.D. Late budding domains and host proteins in enveloped virus release. Virology 344, 55-63 (2006).
3. Morita, E. & Sundquist, W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20, 395-425 (2004).
4. Garrus, J.E. et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65 (2001).
5. Gottlinger, H.G., Dorfman, T., Sodroski, J.G. & Haseltine, W.A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA 88, 3195-3199 (1991).
6. Huang, M., Orenstein, J.M., Martin, M.A. & Freed, E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69, 6810-6818 (1995).
7. Demirov, D.G., Ono, A., Orenstein, J.M. & Freed, E.O. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. USA 99, 955-960 (2002).
8. Martin-Serrano, J., Zang, T. & Bieniasz, P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7, 1313-1319 (2001).
9. VerPlank, L. et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. USA 98, 7724-7729 (2001).
10. Strack, B., Calistri, A., Craig, S., Popova, E. & Gottlinger, H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114, 689-699 (2003).
11. von Schwedler, U.K. et al. The protein network of HIV budding. Cell 114, 701-713 (2003).
12. Vincent, O., Rainbow, L., Tilburn, J., Arst, H.N., Jr. & Penalva, M.A. YPXL/I is a protein interaction motif recognized by Aspergillus PalA and its human homologue, AIP1/Alix. Mol. Cell. Biol. 23, 1647-1655 (2003).
13. Puffer, B.A., Parent, L.J., Wills, J.W. & Montelaro, R.C. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J. Virol. 71, 6541-6546 (1997).
14. Chen, C., Vincent, O., Jin, J., Weisz, O.A. & Montelaro, R.C. Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding. J. Biol. Chem. 280, 40474-40480 (2005).
15. Martin-Serrano, J., Yarovoy, A., Perez-Caballero, D. & Bieniasz, P.D. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. USA 100, 12414-12419 (2003).
16. Hurley, J.H. & Emr, S.D. The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annu. Rev. Biophys. Biomol. Struct. 35, 277-298 (2006).
17. Odorizzi, G. The multiple personalities of Alix. J. Cell Sci. 119, 3025-3032 (2006).
18. Williams, R.L. & Urbe, S. The emerging shape of the ESCRT machinery. Nat. Rev. Mol. Cell Biol. 8, 355-368 (2007).
19. Carlton, J.G. & Martin-Serrano, J. Parallels between cytokinesis and retroviral budding-a role for the ESCRT machinery. Science 316, 1908-1912 (2007).
20. Muziol, T. et al. Structural basis for budding by the ESCRT-III factor CHMP3. Dev. Cell 10, 821-830 (2006).
21. Langelier, C. et al. Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J. Virol. 80, 9465-9480 (2006).
22. Kim, J. et al. Structural basis for endosomal targeting by the Bro1 domain. Dev. Cell 8, 937-947 (2005).
23. Bowers, K. et al. Protein-protein interactions of ESCRT complexes in the yeast Saccharomyces cerevisiae. Traffic 5, 194-210 (2004).
24. Pornillos, O., Alam, S.L., Davis, D.R. & Sundquist, W.I. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat. Struct. Biol. 9, 812-817 (2002).
25. Pornillos, O. et al. Structure and functional interactions of the Tsg101 UEV domain. EMBO J. 21, 2397-2406 (2002).
26. Fisher, R.D. et al. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128, 841-852 (2007).
27. Usami, Y., Popov, S. & Gottlinger, H.G. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 that depends on its CHMP4 binding site. J. Virol. 81, 6614-6622 (2007).
28. Bibollet-Ruche, F. et al. New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade. J. Virol. 78, 7748-7762 (2004).
29. Lee, S., Joshi, A., Nagashima, K., Freed, E.O. & Hurley, J.H. Structural basis for viral late-domain binding to Alix. Nat. Struct. Mol. Biol. 14, 194-199 (2007).
30. Odorizzi, G., Katzmann, D.J., Babst, M., Audhya, A. & Emr, S.D. Bro1 is an endosome-associated protein that functions in the MVB pathway in Saccharomyces cerevisiae. J. Cell Sci. 116, 1893-1903 (2003).
31. 2+-dependent reaction. J. Biol. Chem. 274, 1533-1540 (1999).
32. Missotten, M., Nichols, A., Rieger, K. & Sadoul, R. Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ. 6, 124-129 (1999).
33. Chen, B., Borinstein, S.C., Gillis, J., Sykes, V.W. & Bogler, O. The glioma-associated protein SETA interacts with AIP1/Alix and ALG-2 and modulates apoptosis in astrocytes. J. Biol. Chem. 275, 19275-19281 (2000).
34. Chatellard-Causse, C. et al. Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to endophilins and induces cytoplasmic vacuolization. J. Biol. Chem. 277, 29108-29115 (2002).
35. Tsuda, M., Seong, K.H. & Aigaki, T. POSH, a scaffold protein for JNK signaling, binds to ALG-2 and ALIX in Drosophila. FEBS Lett. 580, 3296-3300 (2006).
36. Munshi, U.M., Kim, J., Nagashima, K., Hurley, J.H. & Freed, E.O. An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. J. Biol. Chem. 282, 3847-3855 (2007).
37. Martin-Serrano, J., Perez-Caballero, D. & Bieniasz, P.D. Context-dependent effects of L domains and ubiquitination on viral budding. J. Virol. 78, 5554-5563 (2004).
38. Geminard, C., De Gassart, A., Blanc, L. & Vidal, M. Degradation of AP2 during reticulocyte maturation enhances binding of hsc70 and Alix to a common site on TFR for sorting into exosomes. Traffic 5, 181-193 (2004).
39. Costa, L.J. et al. Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. Retrovirology 3, 33 (2006).
40. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. In Methods in Enzymology Vol. 276 (eds. Carter, C.W., Jr. & Sweet, R.M.) 307-326 (Academic Press, New York, 1997).
41. Murshudov, G.N., Vagin, A.A. & Dodson, E. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255 (1997).
42. Merritt, E.A. & Painter, J. TLSMD web server for the generation of multi-group TLS models. J. Appl. Cryst. 39, 109-111 (2006).
43. Painter, J. & Merritt, E.A. Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D Biol. Crystallogr. 62, 439-450 (2006).
44. Murshudov, G.N., Vagin, A.A., Lebedev, A., Wilson, K.S. & Dodson, E.J. Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr. D 55, 247-255 (1999).
45. Howlin, B., Butler, S.A., Moss, D.S., Harris, G.W. & Driessen, H.P.C. TLSANL: TLS parameter analysis program for segmented anisotropic refinement of macromolecular structures. J. Appl. Cryst. 26, 622-624 (1993).
46. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
47. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
48. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
49. Laskowski, R.A., Moss, D.S. & Thornton, J.M. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231, 1049-1067 (1993).
50. Johnsson, B., Lofas, S. & Lindquist, G. Immobilization of proteins to a carboxymethyl-dextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198, 268-277 (1991).
51. Myszka, D.G. Improving biosensor analysis. J. Mol. Recognit. 12, 279-284 (1999).
52. DeLano, W.L. The PyMOL Molecular Graphics System (DeLano Scientific, San Carlos, California, USA, 2002).